Evaluation of efficacy and tolerability of oral terbinafine in seborrhoeic dermatitis;Valutazione dell'efficacia e della tollerabilita della terbinafina orale nella dermatite seborroica. Studio multicentrico calabro-lucano

Annali Italiani di Dermatologia Allergologica Clinica e Sperimentale

Volumn 53, Issue 3, 1999, Pages 85-91

  Vena, Gino Antonio ^a   Loconsole, Francesco ^a   Cassano, Nicoletta ^b   Curia, Sandra ^b   Priolo, Stefano ^b   Donato, Lorenzo ^b   Ferrari, Angelo ^b   Calabretta, Vincenza ^b   Lopreiato, Raffaele ^b   Catalani, Gaetano ^b   Gardi, Luigi ^b   Russo, Francesco ^b   Catalano, Maria Rosa ^b   Gargano, Nicola ^b   Verrina, Francesco ^b   Cimino, Leonardo ^b   Fiorenza, Antonella ^b   Primerano, Loredana ^b   Zoccali, Andrea ^b   Riccardi, Eustachio ^b   Sadeh, Tewfiq ^b   Fiamma, Giuseppe ^b   Ricciuti, Federico ^b   Eufemia, Giovanni ^b   Meo, Anna Laura ^b   Anastasio, Francesco ^b   Cento, Filippo ^b   Algeri, Filomena ^b   Corcione, Agostino ^b   more..

^a UNIVERSITY OF BARI   (Italy)

^b Policlinico ^*

Author keywords

Oral terbinafine; Seborrhoeic dermatitis; Therapy

Indexed keywords

TERBINAFINE;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL TRIAL; DERMATITIS; DRUG EFFICACY; DRUG INDUCED DISEASE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; SEBORRHEIC DERMATITIS; TREATMENT OUTCOME;

EID: 6744231363     PISSN: 0365169X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Balfour JA, Faulds D. Terbinafine: a review of its pharmacodynamics and pharmacokinetic properties, and therapeutic potential in superficial mycoses. Drugs 1992; 43: 259.
2. Rosen T, Schell BJ, Orengo I. Anti-inflammatory activity of antifungal preparations. Int J Dermatol 1997; 36: 788.
3. Gulliver WP, Gulliver B, Marsolais C. Treatment of seborrheic dermatitis with 1% terbinafine (Lamisil ®) cream. In: Hay RJ (ed). International perspective on Lamisil. London: CCT Healthcare Communications Ltd, 1994; 101: 66.
4. Aste N, Fumo G, Grande S, et al. Terbinafina crema nel trattamento della dermatite seborroica: dati preliminari clinici e sebometrici. Atti del 70° Congresso Nazionale SIDEV, Santa Margherita di Pula, Cagliari, 7-10 giugno 1995.
5. Skorepovà M. Ucinek 1% terbinafin krému u seboroické dermatitidy obliceje. Ceskosl Dermatol 1995; 70: 192.
6. Faergemann J, Jones TC, Hettler O, et al. Pityrosporum ovale (Malassezia furfur) as the causative agent of seborrhoeic dermatitis: new treatment options. Br J Dermatol 1996: 134 (suppl 46): 12.
7. Cassano N, Loconsole F, Mastrolonardo M, et al. Terbinafina orale nella dermatite seborroica: meccanismo d'azione ed esperienze cliniche preliminari. In: Bartoletti CA (ed). Medicina estetica: metodologie diagnostiche. preventive e correttive. Roma: Editrice Salus Internazionale, 1998: 757.
8. Cassano N, Loconsole F, Torlone G, et al. Terbinafina orale: esperienze cliniche nella dermatite seborroica. Atti del 73° Congresso Nazionale SIDEV, San Martino aJ Cimino (VT), 3-6 giugno 1998.
9. Shuster S. The aetiology of dandruff and the mode of action of therapeutic agents. Br J Dermatol 1984; 111: 235.
10. Clift DC, Dodd HJ, Kirby JDT. et al. Seborrheic dermatitis and malignancy: an investigation of the skin flora. Acta Derm Venereol (Stockh) 1988; 68: 48.
11. Schopf R. Eczema seborroico. In: Marks R (ed). Eczema Ed. italiana, London: Martin Dunitz, 1993: 129.
12. Caprilli F. The role of Pityrosporum in seborrhoeic dermatitis. In: Ippolito F (ed). Proceedings of Simposyum on Seborrhoeic dermatitis. Rome, 17 April 1993. Boll Ist Dermatol S. Gallicano 1994; 14: 9.
13. Ford GP, Farr PM, Ive FA, et al. The response of seborrhoeic dermatitis to ketoconazole. Br J Dermatol 1984; 111: 603.
14. Skinner RBJr, Noah PW, Taylor RM, et al. Double blind treatment of seborrheic dermatitis with 2% ketoconazole cream. J Am Acad Dermatol 1985; 12: 852.
15. Rigoni C, Vigo GP, Motta S, et al. Oral treatment with itraconazole in patients with seborrheic dermatitis and pityriasis capitis: clinical, mycological and laboratory evaluation. 19th World Congress of Dermatology, Sydney 15-20 June1997.
16. Bertens JR, Loots W, Somers Y, et al. Ketoconazole inhibits the biosynthesis of leukotrienes in vitro and in vivo. Biochem Pharmacol 1986; 35: 883.
17. Steinhilber D, Jaschonek K, Knospe J, et al. Effects of novel antifungal azole derivatives on the 5-lipooxygenase and cyclooxygenase pathway. Arzneimittelforschung 1990; 40: 1260.
18. Vena GA, Coviello C, Loconsole F, et al. Trattamento della dermatite seborroica con una crema contenente furalglucitolo. Ann Ital Dermatol Clin Sper 1996; 50: 3.
19. Vena GA, Cassano N, Mastrolonardo M, et al. Management of some inflammatory dermatoses with a cosmetic preparation containing antioxidant/antiinflammatory agents. G Ital Derm Venereol 1998; 133: 373.
20. Jensen JC. Pharmacokinetics of Lamisil ® in humans. J Derm Treat 1990; 1 (suppl 2): 15.
21. Faergemann J, Zehender H, Jones T, et al. Terbinafine levels in serum, stratum corneum, dermis-epidermis (without stratum corneum), hair, sebum and eccrine sweat. Acta Derm Venereol (Stockh) 1990; 71: 322.
22. Villars W, Jones TC. Present status of the efficacy and tolerability of terbinafine (Lamisil®) used systemically in the treatment of dermatomycoses of skin and nails. J Derm Treat 1990; 1 (suppl 2): 33.
23. Villars VV, Jones TC. Special features of the clinical use of oral terbinafine in the treatment of fungal diseases. Br J Dermatol 1992; 126 (suppl 39): 61.
24. Leeming JP, Sansom JE, Burton JL. Susceptibility of Malassezia furfur subgroups to terbinafine. Br J Dermatol 1997; 137: 764.
25. Cowley NC, Farr PM, Shuster S. The permissive effect of sebum in seborrhoeic dermatitis: an explanation of the rash in neurological disorders. Br J Dermatol 1990; 122: 71.
26. Kassan D, Choi T, Lee W, et al. Effect of allylamines on lymphocyte adhesion to human microvascular endothelia. Clin Res 1994; 42: 462.
27. Silverberg N, Wei-Li L, Shalita AR. Effects of terbinafine on leukocyte surface marker expression. J Invest Dermatol 1995; 104: 693.
28. Fabbri P, Geti V. Dermatite seborroica: aspetti immunologici. Micol Dermatol 1991; 5: 55.
29. Picardo M, Colombo D, De Luca C, et al. Free radical scavanger activity of terbinafine in vitro. Proceedings of the International Summit on Cutaneous antifugal therapy, New York, 24-27 August 1995.
30. Camera E, Cannistraci C, Briganti S, et al. Scavenging effects of terbinafine on free radicals in vitro. Br J Dermatol 1999; 140: 640.
31. Passi S, Morrone M, De Luca C, et al. Blood levels of vitamin E, polyunsaturated fatty acids of phospholipids lipoperoxides and glutathione peroxidase in patients affected with seborrhoeic dermatitis. J Dermatol Sci 1991; 2: 171.
32. Raho G, D'Argento V, Cassano N, et al. Superossidodismutasi come marker da stress ossidativo nelle orticarie fisiche e dermatiti seborroiche. Atti della Riunione SIDEV Interregionale Centro Sud e Isole. Catania, 24-25 ottobre 1998.
33. Ippolito F, Passi S, Picardo M, et al. La patogenesi della dermatite seborroica alla luce del risultati di una terapia innovativa. G Ital Derm Venereol 1992; 127: 1.